These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4308291)

  • 1. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Derivatives of viomycin. I. Preparation and properties of viomycin nicotinate and isonicotinate].
    Sobiczewski W; Cieślak J; Waszkiewicz A; Chojnowski W
    Acta Pol Pharm; 1968; 25(4):403-5. PubMed ID: 4299475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viomycin derivatives. IV. Preparation and properties of some penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1969; 26(1):29-32. PubMed ID: 4305691
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of some viomycinmethyltetracyclines].
    Sobiczewski W; Cendrowska H; Chojnowski W
    Acta Pol Pharm; 1969; 26(6):505-10. PubMed ID: 4314647
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1968; 25(4):407-10. PubMed ID: 4299476
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on viomycin. XIV. Roles of basic and cyclic moieties in the antimicrobial activity of viomycin.
    Kitagawa T; Miura T; Kurose H
    Chem Pharm Bull (Tokyo); 1979 Nov; 27(11):2551-6. PubMed ID: 230912
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
    Kitagawa T; Miura T; Takaishi M; Taniyama H
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between antimicrobial activities and chemically reactive functions in viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1972 Jul; 25(7):429-31. PubMed ID: 4350197
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical studies the mechanism of action of isoniazid].
    Nestler HJ
    Arzneimittelforschung; 1966 Nov; 16(11):1442-7. PubMed ID: 4234663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of antibiotics on the adhesive properties of thrombocytes].
    Zolotukhin SI; Mironova MI
    Farmakol Toksikol; 1969; 32(4):460-3. PubMed ID: 4311478
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships between antimicrobial activities and chemical structures of reduced products of viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1973 Sep; 26(9):528-31. PubMed ID: 4365319
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro sensitivity of various micro-organisms from animal sources to viomycin].
    DEOM J; MORTELMANS J
    Antonie Van Leeuwenhoek; 1955; 21(4):377-81. PubMed ID: 13327858
    [No Abstract]   [Full Text] [Related]  

  • 17. [The activity of nicotinic acid hydroxylase and pyrocatechase in chemosensitive mycobacteria and their chemoresistant variants].
    Lippelt CH; Bönicke R
    Zentralbl Bakteriol Orig; 1968; 209(1):62-71. PubMed ID: 4317775
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
    Engbaek HC; Vergmann B; Baess I
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(5):619-31. PubMed ID: 4322001
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viomycin sulfate and viothenattoxic and side-effects in the treatment of chronic cases of tuberculosis].
    ZELENKA M; JANCIK E
    Tuberkulosearzt; 1962 Aug; 16():500-5. PubMed ID: 14010064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.